Skip to content

Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms

Phase III Randomized Controlled Trial of a Collaborative Care Intervention to Manage Cancer Related Symptoms in Patients Diagnosed With Hepatobiliary Carcinoma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01640522
Acronym
CaSSY
Enrollment
261
Registered
2012-07-13
Start date
2008-01-31
Completion date
2014-12-31
Last updated
2024-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile Duct Cancer, Colorectal Carcinoma, Gallbladder Cancer, Hepatocellular Carcinoma, Liver Metastases, Pancreatic Cancer, Primary Liver Cancer

Keywords

Hepatocellular carcinoma, Cholangio carcinoma, Primary Liver Cancer, Bile Duct CancerPancreatic Cancer, Gallbladder Cancer, Colorectal Carcinoma, Other Primary Cancers with Liver Metastases

Brief summary

The purpose of this study is to test the efficacy of a collaborative care intervention to manage cancer-related symptoms and improve health related quality of life in patients diagnosed with hepatobiliary carcinoma.

Detailed description

The study is a collaborative care intervention designed to reduce pain, fatigue, and depressive symptoms and improve overall health related quality of life.

Interventions

OTHERCollaborative Care

Collaborative care intervention to manage cancer-related symptoms

OTHEREnhanced usual Care

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

Only person evaluating outcomes

Intervention model description

Intervention versus standard of care

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* biopsy, radiological, and/or biological evidence of hepatobiliary carcinoma * age 18 years or older * fluency in English.

Exclusion criteria

included:

Design outcomes

Primary

MeasureTime frameDescription
DepressionChange from baseline at 6 and 12 monthsCenter for Epidemiological Studies-Depression scale

Secondary

MeasureTime frameDescription
FatigueChange from baseline at 6 and 12 monthsFunctional Assessment of Cancer Therapy-Fatigue

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026